Microbiome changes associated with acute and chronic pancreatitis: A systematic review

• Published in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] Vol. 21; no. 1; pp. 1 - 14
• Main Authors: Brubaker, L., Luu, S., Hoffman, Kl, Wood, A., Navarro Cagigas, M., Yao, Q., Petrosino, Jf, Fisher, W., Van Buren, G.
• Format: Journal Article
• Language: English
• Published: Switzerland Elsevier B.V 01-01-2021; Elsevier Limited
• Subjects: Bias; Case reports; Community composition; Digestive system; Disease; Endoscopy; Gastrointestinal Microbiome - physiology; Gastrointestinal tract; Genomes; Gut microbiome; Humans; Intestinal microflora; Intestine; Metabolism; Microbiomes; Microbiota; Pancreas; Pancreatitis; Pancreatitis - metabolism; Pancreatitis - microbiology; Pancreatitis, Chronic - metabolism; Pancreatitis, Chronic - microbiology; Review; Systematic review; Pancreas; Gut microbiome; Review
• ISSN: 1424-3903; 1424-3911
• DOI: 10.1016/j.pan.2020.12.013

Altered intestinal microbiota has been reported in pancreatic disorders, however, it remains unclear whether these changes alter the course of disease in patients with acute (AP) and chronic pancreatitis (CP), or whether these disease states alter the environment to enable pathogenic microbial composition changes to occur. We undertook a systematic review to characterize the gut microbiome in pancreatitis patients.
MEDLINE and EMBASE were searched for studies on microbiota in pancreatitis published from January 1, 2000 to June 5, 2020. Animal studies, reviews, case reports, and non-English articles were excluded. A frequency analysis was performed for outcomes reported in ≥2 studies and studies were analyzed for risk of bias and quality of evidence.
22 papers met inclusion criteria; 15 included AP, 7 included CP. No studies were appropriately designed to assess whether alterations in the gut microbiome exacerbate pancreatitis or develop as a result of pancreatitis. We did identify several patterns of microbiome changes that are associated with pancreatitis. The gut microbiome demonstrated decreased alpha diversity in 3/3 A P studies and 3/3 C P studies. Beta diversity analysis revealed differences in bacterial community composition in the gut microbiome in 2/2 A P studies and 3/3 C P studies. Functionally, gut microbiome changes were associated with infectious pathways in AP and CP. Several studies suffered from high risk of bias and inadequate quality.
Detecting differences in microbial composition associated with AP and CP may represent a diagnostic tool. Appropriately controlled longitudinal studies are needed to determine whether microbiome changes are causative or reactive in pancreatitis.